DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22
Carl Zeiss Meditec generated revenue of 1,332.9m in the first nine months of fiscal year 2021/22 (prior year: 1,198.2m), corresponding to an increase of 11.2% (adjusted for currency effects: +9.8%) compared with the same period of the prior year.
- Carl Zeiss Meditec generated revenue of 1,332.9m in the first nine months of fiscal year 2021/22 (prior year: 1,198.2m), corresponding to an increase of 11.2% (adjusted for currency effects: +9.8%) compared with the same period of the prior year.
- Order intake increased at a much higher rate than revenue, rising 36.0% to 1,750.5m (prior year: 1,287.6m).
- I am therefore highly satisfied with the very solid revenue growth and the even stronger order intake.
- Revenue growth, as well as in particular the increasing share of recurring revenue and favorable currency effects, had a positive impact on operating result.